miR‐145 is a potential biomarker for predicting clinical outcome in glioblastomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR‐145 is a potential biomarker for predicting clinical outcome in glioblastomas

Published:2018-11-28 Issue:5 Volume:120 Page:8016-8020
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Shi Lei¹^ORCID,Wang Bin¹,Gu Xiaoyan²,Zhang Shuguang¹,Li Xiaoliang¹,Zhu Haifeng³^ORCID

Affiliation:

1. Department of Neurosurgery First People’s Hospital of Kunshan, affiliated with Jiangsu University Suzhou China

2. Department of Rehabilitation The Affiliated Jiangning Hospital of Nanjing Medical University Nanjing China

3. Department of Neurosurgery Funing People’s Hospital Funing China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.28079

Reference21 articles.

1. MicroRNA‐129‐3p suppresses tumor growth by targeting E2F5 in glioblastoma;Fang DZ;Eur Rev Med Pharmacol Sci,2018

2. miRNA‐320a inhibits glioma cell invasion and migration by directly targeting aquaporin 4;Xiong W;Oncol Rep,2018

3. miR-21 Is Linked to Glioma Angiogenesis

4. CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways

5. The epidemiology of glioma in adults: a "state of the science" review

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression;International Journal of Molecular Sciences;2023-04-22

2. The miR-145–MMP1 axis is a critical regulator for imiquimod-induced cancer stemness and chemoresistance;Pharmacological Research;2022-05

3. MicroRNA‐145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6;The FASEB Journal;2020-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3